Advances of Smart Stimulus‐Responsive Microneedles in Cancer Treatment

Abstract Microneedles (MNs) have emerged as a highly promising technology for delivering drugs via the skin. They provide several benefits, including high drug bioavailability, non‐invasiveness, painlessness, and high safety. Traditional strategies for intravenous delivery of anti‐tumor drugs have risks of systemic toxicity and easy development of drug resistance, while MN technology facilitates precise delivery and on‐demand release of drugs in local tissues. In addition, by further combining with stimulus‐responsive materials, the construction of smart stimulus‐responsive MNs can be achieved, which can respond to specific physical/chemical stimuli from the internal or external environment, thereby further improving the accuracy of tumor treatment and reducing toxicity to surrounding tissues/cells. This review systematically summarizes the classification, materials, and reaction mechanisms of stimulus‐responsive MNs, outlines the benefits and challenges of various types of MNs, and details their application and latest progress in cancer treatment. Finally, the development prospects of smart MNs in tumor treatment are also discussed, bringing inspiration for future precision treatment of tumors.